- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUL.2: 6 residues within 4Å:- Chain A: N.65, D.66, W.356, I.388
- Chain B: N.382, F.385
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.66
NAG-NAG-BMA-FUL.14: 6 residues within 4Å:- Chain C: N.65, D.66, W.356, I.388
- Chain D: N.382, F.385
No protein-ligand interaction detected (PLIP)- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.3: 9 residues within 4Å:- Chain A: D.116, N.119
- Chain B: D.318, S.319, D.320, Y.372, G.373, T.374, G.375
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:T.374
- Hydrogen bonds: B:S.319, B:S.319, B:D.320
NAG-NAG-BMA-MAN-MAN-MAN.7: 9 residues within 4Å:- Chain B: D.116, N.119
- Chain C: D.318, S.319, D.320, Y.372, G.373, T.374, G.375
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:T.374
- Hydrogen bonds: C:D.318, C:S.319, C:S.319, C:D.320
NAG-NAG-BMA-MAN-MAN-MAN.15: 9 residues within 4Å:- Chain C: D.116, N.119
- Chain D: D.318, S.319, D.320, Y.372, G.373, T.374, G.375
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:T.374
- Hydrogen bonds: D:D.318, D:S.319, D:S.319, D:D.320
NAG-NAG-BMA-MAN-MAN-MAN.19: 9 residues within 4Å:- Chain A: D.318, S.319, D.320, Y.372, G.373, T.374, G.375
- Chain D: D.116, N.119
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:T.374
- Hydrogen bonds: A:S.319, A:S.319, A:D.320
- 4 x NAG- NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NDG.4: 9 residues within 4Å:- Chain A: N.5, I.152, N.153, Y.203, P.204, M.226, E.227
- Ligands: NAG-NAG.1, NAG-NAG.1
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.152
- Hydrogen bonds: A:N.153, A:Y.203
NAG-NDG.8: 9 residues within 4Å:- Chain B: N.5, I.152, N.153, Y.203, P.204, M.226, E.227
- Ligands: NAG-NAG.5, NAG-NAG.5
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.152
- Hydrogen bonds: B:N.153, B:Y.203
NAG-NDG.16: 9 residues within 4Å:- Chain C: N.5, I.152, N.153, Y.203, P.204, M.226, E.227
- Ligands: NAG-NAG.13, NAG-NAG.13
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:I.152
- Hydrogen bonds: C:N.153, C:Y.203
NAG-NDG.20: 9 residues within 4Å:- Chain D: N.5, I.152, N.153, Y.203, P.204, M.226, E.227
- Ligands: NAG-NAG.17, NAG-NAG.17
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:I.152
- Hydrogen bonds: D:N.153, D:Y.203
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.6: 6 residues within 4Å:- Chain B: N.65, D.66, W.356, I.388
- Chain C: N.382, F.385
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.66
NAG-NAG-BMA-FUC.18: 6 residues within 4Å:- Chain A: N.382, F.385
- Chain D: N.65, D.66, W.356, I.388
No protein-ligand interaction detected (PLIP)- 4 x CA: CALCIUM ION(Non-covalent)
CA.9: 6 residues within 4Å:- Chain A: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.212, A:G.216, A:G.264, A:T.265, A:Q.266
CA.11: 6 residues within 4Å:- Chain B: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.212, B:G.216, B:G.264, B:T.265, B:Q.266
CA.21: 6 residues within 4Å:- Chain C: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.212, C:G.216, C:G.264, C:T.265, C:Q.266
CA.23: 6 residues within 4Å:- Chain D: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.212, D:G.216, D:G.264, D:T.265, D:Q.266
- 4 x ST3: 4-(ACETYLAMINO)-3-AMINO BENZOIC ACID(Non-covalent)
ST3.10: 9 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.97, E.146, R.211, R.290, Y.325
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:D.70, A:R.71
- Hydrogen bonds: A:D.70, A:R.71, A:E.146, A:R.211, A:Y.325
- Salt bridges: A:R.37, A:R.290
ST3.12: 9 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.97, E.146, R.211, R.290, Y.325
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:D.70, B:R.71
- Hydrogen bonds: B:R.71, B:E.146, B:R.211, B:Y.325
- Salt bridges: B:R.37, B:R.290
ST3.22: 9 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.97, E.146, R.211, R.290, Y.325
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:D.70, C:R.71
- Hydrogen bonds: C:R.71, C:E.146, C:E.146, C:R.211, C:Y.325
- Salt bridges: C:R.37, C:R.290
ST3.24: 9 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.97, E.146, R.211, R.290, Y.325
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:D.70, D:R.71
- Hydrogen bonds: D:D.70, D:R.71, D:E.146, D:E.146, D:R.211, D:Y.325
- Salt bridges: D:R.37, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jedrzejas, M.J. et al., Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry (1995)
- Release Date
- 1995-03-31
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ST3: 4-(ACETYLAMINO)-3-AMINO BENZOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jedrzejas, M.J. et al., Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry (1995)
- Release Date
- 1995-03-31
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B